Shimadzu Displays New Automated Bioanalytical Systems
The company demonstrated integrated sample preparation workflows to boost throughput in pharmaceutical research labs.
Updated on Oct. 28, 2026 in Biotech
Live Poll
Do you trust that new analytical technology innovations effectively improve the safety of drug development?
Shimadzu demonstrated its latest analytical instrumentation and automated workflows for pharmaceutical research at the AAPS 2026 PharmSci 360 conference in New Orleans. The exhibit featured systems including the GCMS-TQ RX Series and integrated sample preparation pipelines.
Why it matters
As pharmaceutical manufacturing moves toward higher levels of automation, companies like Shimadzu are focusing on end-to-end integration to increase lab throughput. These exhibits align with industry demand for standardized bioanalytics and automated workflows in drug development.
Shimadzu displayed the GCMS-TQ RX Series, Nexera Prep LC, and specialized oligonucleotide characterization software. These systems represent the latest iteration of the company's liquid and gas chromatography-mass spectrometry analytical platforms.
The players
Shimadzu
A global manufacturer of analytical instrumentation, specialized laboratory hardware, and clinical diagnostic systems.
ePrep
An automation company that designs hardware and software for liquid handling and sample preparation workflows.
The details
The showcased systems utilize automated sample preparation pipelines, developed in partnership with ePrep, to remove manual intervention from the analytical cycle. By integrating these workflows, laboratories aim to reduce human error during sample processing. The Nexera Prep LC — a liquid chromatography system used for purifying and separating compounds — serves as a key component in these automated setups.
Timeline
October 25-28, 2026: The AAPS 2026 PharmSci 360 conference took place in New Orleans.
The Tech Race
This integration effort places Shimadzu among firms aiming to solve the automation bottleneck in modern pharmaceutical analysis. It follows a wider industry move toward fully automated pipelines to replace labor-intensive manual methods in analytical chemistry.
Pharmaceutical labs seeking to optimize their workflow pipelines can now look to these integrated systems for high-throughput sample processing. The equipment is intended for professional use in research and manufacturing environments, with availability determined by manufacturer specifications.
The takeaway
Shimadzu is shifting toward fully automated, end-to-end analytical solutions to meet pharmaceutical industry standards. Industry observers should monitor for third-party validation reports or white papers detailing the throughput increases provided by these new automated pipeline configurations.
Further reading
For more on emerging laboratory automation technologies, explore the latest trends in Biotech.
Source note: This article includes information reported by Selectscience.
Live Poll
Do you trust that new analytical technology innovations effectively improve the safety of drug development?
